262 related articles for article (PubMed ID: 14603552)
1. Polycythemia vera: a review.
Golden C
Clin J Oncol Nurs; 2003; 7(5):553-6. PubMed ID: 14603552
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
Berk PD; Goldberg JD; Donovan PB; Fruchtman SM; Berlin NI; Wasserman LR
Semin Hematol; 1986 Apr; 23(2):132-43. PubMed ID: 3704665
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and therapy of polycythemia vera.
Lengfelder E; Merx K; Hehlmann R
Semin Thromb Hemost; 2006 Apr; 32(3):267-75. PubMed ID: 16673281
[TBL] [Abstract][Full Text] [Related]
4. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Nand S; Stock W; Godwin J; Fisher SG
Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
[TBL] [Abstract][Full Text] [Related]
5. [Efficacious treatment of a fatal blood disease: polycythemia vera].
Sánchez Fayos J; Román Barbero A; Nevado Reviriego I
Sangre (Barc); 1997 Jun; 42(3):215-8. PubMed ID: 9381264
[No Abstract] [Full Text] [Related]
6. Neurologic complications of polycythemia and their impact on therapy.
Newton LK
Oncology (Williston Park); 1990 Mar; 4(3):59-64; discussion 64-6. PubMed ID: 2144446
[TBL] [Abstract][Full Text] [Related]
7. Polycythemia vera.
Stuart BJ; Viera AJ
Am Fam Physician; 2004 May; 69(9):2139-44. PubMed ID: 15152961
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular events and intensity of treatment in polycythemia vera.
Marchioli R; Finazzi G; Specchia G; Cacciola R; Cavazzina R; Cilloni D; De Stefano V; Elli E; Iurlo A; Latagliata R; Lunghi F; Lunghi M; Marfisi RM; Musto P; Masciulli A; Musolino C; Cascavilla N; Quarta G; Randi ML; Rapezzi D; Ruggeri M; Rumi E; Scortechini AR; Santini S; Scarano M; Siragusa S; Spadea A; Tieghi A; Angelucci E; Visani G; Vannucchi AM; Barbui T;
N Engl J Med; 2013 Jan; 368(1):22-33. PubMed ID: 23216616
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of arterial compliance in polycythemia vera patients: short and long-term influence of phlebotomy.
Nemets A; Isakov I; Huerta M; Barshai Y; Oren S; Lugassy G
Isr Med Assoc J; 2006 Dec; 8(12):845-7. PubMed ID: 17214101
[TBL] [Abstract][Full Text] [Related]
10. Risk stratification, staging, and treatment of patients with polycythemia vera: Italian and European collaboration on low-dose aspirin in polycythemia data.
Finazzi G
Semin Thromb Hemost; 2006 Apr; 32(3):276-82. PubMed ID: 16673282
[TBL] [Abstract][Full Text] [Related]
11. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
[TBL] [Abstract][Full Text] [Related]
12. Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea.
Alvarez-Larrán A; Pérez-Encinas M; Ferrer-Marín F; Hernández-Boluda JC; Ramírez MJ; Martínez-López J; Magro E; Cruz Y; Mata MI; Aragües P; Fox ML; Cuevas B; Montesdeoca S; Hernández-Rivas JA; García-Gutiérrez V; Gómez-Casares MT; Steegmann JL; Durán MA; Gómez M; Kerguelen A; Bárez A; García MC; Boqué C; Raya JM; Martínez C; Albors M; García F; Burgaleta C; Besses C;
Haematologica; 2017 Jan; 102(1):103-109. PubMed ID: 27686377
[TBL] [Abstract][Full Text] [Related]
13. A contemporary approach to the diagnosis and management of polycythemia vera.
Tefferi A
Curr Hematol Rep; 2003 May; 2(3):237-41. PubMed ID: 12901345
[TBL] [Abstract][Full Text] [Related]
14. Polycythemia vera: diagnosis, treatment, and relationship to leukemia.
Walsh JR
Geriatrics; 1978 May; 33(5):61-3, 66-9. PubMed ID: 640388
[No Abstract] [Full Text] [Related]
15. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyurea: The drug of choice for polycythemia vera and essential thrombocythemia.
Dingli D; Tefferi A
Curr Hematol Malig Rep; 2006 Jun; 1(2):69-74. PubMed ID: 20425334
[TBL] [Abstract][Full Text] [Related]
17. Survival in a patient with polycythaemia vera for over thirty years: implications for treatment decisions in younger patients.
Samuelsson J
Leuk Lymphoma; 1998 Dec; 32(1-2):195-8. PubMed ID: 10037017
[TBL] [Abstract][Full Text] [Related]
18. Polycythemia rubra vera.
Bilgrami S; Greenberg BR
Semin Oncol; 1995 Aug; 22(4):307-26. PubMed ID: 7638629
[TBL] [Abstract][Full Text] [Related]
19. Hyperviscosity in polycythemia vera and other red cell abnormalities.
Kwaan HC; Wang J
Semin Thromb Hemost; 2003 Oct; 29(5):451-8. PubMed ID: 14631544
[TBL] [Abstract][Full Text] [Related]
20. Polycythemia vera.
Knoop T
Semin Oncol Nurs; 1996 Feb; 12(1):70-7. PubMed ID: 8650444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
